Quantamental Technologies LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Quantamental Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$26.26 - $34.86 $154,566 - $205,185	-5,886 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$17.43 - $28.82 $76,343 - $126,231	-4,380 Reduced 42.67%	5,886 $156,000
Q1 2019 Apr 29, 2019	BUY	$12.05 - $20.18 $102,461 - $171,590	8,503 Added 482.3%	10,266 $188,000
Q4 2018 Jan 28, 2019	BUY	$10.74 - $19.7 $18,934 - $34,731	1,763 New	1,763 $22,000

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.